Martin Madden
Director/Board Member at MICROBOT MEDICAL INC.
Net worth: 191 033 $ as of 2024-04-29
Profile
Martin J.
Madden currently works at NovoCure Ltd., as Independent Director from 2017 and Microbot Medical, Inc., as Independent Director from 2017.
Mr. Madden also formerly worked at TSO3, Inc., as Independent Director from 2018 to 2019, Mardil, Inc., as Director, Johnson & Johnson, as Vice President-Medical Device R&D Transformation from 2016 to 2017, and DePuy Synthes, Inc., as Vice President-Research & Development from 1986 to 2017.
Mr. Madden received his graduate degree from Carnegie Mellon University, Masters Business Admin degree from The Trustees of Columbia University in The City of New York, and undergraduate degree from the University of Dayton.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD.
0.01% | 2024-04-01 | 15,620 ( 0.01% ) | 191 033 $ | 2024-04-29 |
MICROBOT MEDICAL INC
-.--% | 2024-03-24 | 0 ( -.--% ) | - $ | 2024-04-29 |
Martin Madden active positions
| Companies | Position | Start |
|---|---|---|
| MICROBOT MEDICAL INC. | Director/Board Member | 2017-02-05 |
| NOVOCURE LIMITED | Director/Board Member | 2017-05-09 |
Former positions of Martin Madden
| Companies | Position | End |
|---|---|---|
| TSO3 INC. | Director/Board Member | 2019-09-30 |
DePuy Synthes, Inc.
 DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 2015-06-30 |
Mardil, Inc.
 Mardil, Inc. Medical SpecialtiesHealth Technology Mardil, Inc. manufactures and markets cardiovascular medical devices. The firm’s flagship product vent ouch system offers a therapy that addresses the underlying root cause mechanism of functional mitral valve regurgitation through a minimally invasive procedure. The company was founded in 2002 by Srirama Rao, Jai Raman and Gopal Muppirala and is headquartered in Plymouth, MN. | Director/Board Member | - |
Training of Martin Madden
| Carnegie Mellon University | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Dayton | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MICROBOT MEDICAL INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
DePuy Synthes, Inc.
DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Health Technology |
Mardil, Inc.
Mardil, Inc. Medical SpecialtiesHealth Technology Mardil, Inc. manufactures and markets cardiovascular medical devices. The firm’s flagship product vent ouch system offers a therapy that addresses the underlying root cause mechanism of functional mitral valve regurgitation through a minimally invasive procedure. The company was founded in 2002 by Srirama Rao, Jai Raman and Gopal Muppirala and is headquartered in Plymouth, MN. | Health Technology |
TSO3, Inc.
 TSO3, Inc. Medical SpecialtiesHealth Technology TSO3, Inc. is a commercialization-stage medical device company, which engages in the provision of cutting-edge low temperature terminal sterilization technology. Its activities include sale, production, maintenance, research, development, and licensing of sterilization processes, related consumable supplies, and accessories for heat-sensitive medical devices. It operates through the Canada and Worldwide and United States geographical segments. The company was founded by Jocelyn Vézina and Simon Robitaille on June 10, 1998 and is headquartered in Quebec, Canada. | Health Technology |
- Stock Market
- Insiders
- Martin Madden
